A study to determine changes in gene expression induced by obexelimab in B cells from treated patients with IgG4-RD
Latest Information Update: 02 Jan 2024
At a glance
- Drugs Obexelimab (Primary)
- Indications Immunoglobulin G4-related disease
- Focus Pharmacodynamics
Most Recent Events
- 02 Jan 2024 New trial record
- 15 Nov 2023 Results presented at the ACR Convergence 2023